Form 8-K/A · Current Report · Filed 2025-08-08
Agilent Technologies Announces CFO Resignation and Interim CFO Appointment
On July 15, 2025, Agilent Technologies, Inc.
- Filer
- Agilent Technologies Inc. A · NYSE
- Filed
- Accession
- 0001090872-25-000028
- CIK
- 0001090872
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
announced the resignation of Robert W. McMahon as Senior Vice President and Chief Financial Officer. Rodeny Gonsalves has been appointed as interim Chief Financial Officer and interim Principal Financial Officer, effective July 31, 2025. The Compensation Committee approved a bi-weekly salary stipend of $8,654 for Mr. Gonsalves and a grant of restricted stock units valued at $1,000,000, subject to the company's equity award terms.
Items reported
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Market reaction
Close before filing
$113.98
Next session
+0.1%
Since filing
+21.4%
Latest close
$138.37
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from A reporting the same item, with the next session's move:
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Never miss another A filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.